A case of transient elevation of creatinine caused by severe hyperuricemia.

IF 3.2 3区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Clinica Chimica Acta Pub Date : 2025-02-01 Epub Date: 2024-12-27 DOI:10.1016/j.cca.2024.120110
Qiong Wu, Yumeng Gao, Xinyuan Zhang, Wenbo Cui, Shumin Li, Chunyu Luo, Dianjun Mo, Xinqi Cheng
{"title":"A case of transient elevation of creatinine caused by severe hyperuricemia.","authors":"Qiong Wu, Yumeng Gao, Xinyuan Zhang, Wenbo Cui, Shumin Li, Chunyu Luo, Dianjun Mo, Xinqi Cheng","doi":"10.1016/j.cca.2024.120110","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To explore the underlying causes of significant fluctuations in creatinine levels within three days due to transient and severe uric acid elevation, and to provide evidence for the interpretation of abnormal test results and clinical diagnosis and management.</p><p><strong>Methods: </strong>The issues were resolved by retesting the samples, comparing results across different detection platforms, and analyzing the reaction curve. We comprehensively reviewed patients' general conditions, imaging examinations, and treatments. Additionally, we compared pre- and post-admission changes in laboratory indices and performed an extensive literature search for comprehensive analysis.</p><p><strong>Results: </strong>At the patient's first visit, the levels of uric acid (UA), creatinine (CR), and urea (UREA) were measured at 891 umol/L, 211 umol/L, and 7.8 mmol/L, respectively using a Roche full-automatic biochemical analyzer and its corresponding reagents. Subsequent testing yielded 917 umol/L, 211 umol/L, and 8.3 mmol/L for UA, CR, and UREA. After retesting with the Beckman automatic biochemical analyzer and its corresponding reagents, the results for UA, CR, and UREA were 1013 umol/L, 221 umol/L, and 7.75 mmol/L, respectively. The results of the two detection systems were in agreement. A supplementary measurement of Cystatin C (CYSC) at 1.69 mg/L indicates renal dysfunction, consistent with the observed increase in CR levels and ruling out false elevation due to assay-related issues. At 48 h post-admission, untreated, the levels of blood UA, CR, and UREA decreased to 567umol/L, 77umol/L, and 5.1 mmol/L, respectively. Through literature review and analysis, it was determined that the transient abnormal increase in the patient's creatinine level may be attributed to a substantial accumulation of uric acid crystals obstructing the renal tubules, leading to an impediment in renal tubular excretion which subsequently resolves spontaneously.</p><p><strong>Conclusion: </strong>Severe hyperuricemia may result in a transient increase in blood CR levels and could potentially lead to the development of acute uric acid nephropathy. When a clinical laboratory encounters test results inconsistent with the clinical manifestations, it is essential to not only address any potential detection issues but also proactively investigate the underlying reasons for abnormal test results through comprehensive literature reviews and other rigorous methodologies.</p>","PeriodicalId":10205,"journal":{"name":"Clinica Chimica Acta","volume":" ","pages":"120110"},"PeriodicalIF":3.2000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica Chimica Acta","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.cca.2024.120110","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/27 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: To explore the underlying causes of significant fluctuations in creatinine levels within three days due to transient and severe uric acid elevation, and to provide evidence for the interpretation of abnormal test results and clinical diagnosis and management.

Methods: The issues were resolved by retesting the samples, comparing results across different detection platforms, and analyzing the reaction curve. We comprehensively reviewed patients' general conditions, imaging examinations, and treatments. Additionally, we compared pre- and post-admission changes in laboratory indices and performed an extensive literature search for comprehensive analysis.

Results: At the patient's first visit, the levels of uric acid (UA), creatinine (CR), and urea (UREA) were measured at 891 umol/L, 211 umol/L, and 7.8 mmol/L, respectively using a Roche full-automatic biochemical analyzer and its corresponding reagents. Subsequent testing yielded 917 umol/L, 211 umol/L, and 8.3 mmol/L for UA, CR, and UREA. After retesting with the Beckman automatic biochemical analyzer and its corresponding reagents, the results for UA, CR, and UREA were 1013 umol/L, 221 umol/L, and 7.75 mmol/L, respectively. The results of the two detection systems were in agreement. A supplementary measurement of Cystatin C (CYSC) at 1.69 mg/L indicates renal dysfunction, consistent with the observed increase in CR levels and ruling out false elevation due to assay-related issues. At 48 h post-admission, untreated, the levels of blood UA, CR, and UREA decreased to 567umol/L, 77umol/L, and 5.1 mmol/L, respectively. Through literature review and analysis, it was determined that the transient abnormal increase in the patient's creatinine level may be attributed to a substantial accumulation of uric acid crystals obstructing the renal tubules, leading to an impediment in renal tubular excretion which subsequently resolves spontaneously.

Conclusion: Severe hyperuricemia may result in a transient increase in blood CR levels and could potentially lead to the development of acute uric acid nephropathy. When a clinical laboratory encounters test results inconsistent with the clinical manifestations, it is essential to not only address any potential detection issues but also proactively investigate the underlying reasons for abnormal test results through comprehensive literature reviews and other rigorous methodologies.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
一例由严重高尿酸血症引起的肌酐一过性升高。
背景:探讨短暂性、重度尿酸升高所致3天内肌酐水平显著波动的潜在原因,为异常检测结果的解释及临床诊断和处理提供依据。方法:通过对样品进行复测,比较不同检测平台的检测结果,分析反应曲线,解决问题。我们全面回顾了患者的一般情况、影像学检查和治疗方法。此外,我们比较了入院前和入院后实验室指标的变化,并进行了广泛的文献检索以进行全面分析。结果:患者首次就诊时,采用罗氏全自动生化分析仪及相应试剂测定尿酸(UA)、肌酐(CR)、尿素(urea)水平分别为891 umol/L、211 umol/L、7.8 mmol/L。随后的测试结果显示UA、CR和尿素分别为917 umol/L、211 umol/L和8.3 mmol/L。经Beckman全自动生化分析仪及相应试剂复测,UA、CR、尿素分别为1013 umol/L、221 umol/L、7.75 mmol/L。两种检测系统的结果是一致的。补充测量胱抑素C (Cystatin C, CYSC)为1.69 mg/L表明肾功能不全,与观察到的CR水平升高一致,排除了由于检测相关问题导致的假升高。入院后48 h,未经治疗,血液UA、CR和尿素水平分别降至567umol/L、77umol/L和5.1 mmol/L。通过文献回顾和分析,确定患者肌酸酐水平的短暂性异常升高可能是由于尿酸晶体大量积聚阻塞肾小管,导致肾小管排泄障碍,随后自行消退。结论:严重的高尿酸血症可导致血液CR水平的短暂升高,并可能导致急性尿酸肾病的发展。当临床实验室遇到与临床表现不一致的检测结果时,不仅要解决任何潜在的检测问题,而且要通过全面的文献综述和其他严格的方法,积极调查检测结果异常的潜在原因。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinica Chimica Acta
Clinica Chimica Acta 医学-医学实验技术
CiteScore
10.10
自引率
2.00%
发文量
1268
审稿时长
23 days
期刊介绍: The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells. The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal''s scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.
期刊最新文献
Clinicopathological characteristics of patients with low titer anti-phospholipase A2 receptor antibodies verified by indirect immunofluorescence assay. MiR-363: A potential biomarker of kidney diseases. Osteocalcin: A bone protein with multiple endocrine functions. Crispr-cas biosensing for rapid detection of viral infection. Biosensors for early stroke detection.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1